Screener
AbCellera Biologics Inc. ABCL Noncurrent unearned government incentives
Noncurrent unearned government incentives at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:GovernmentAssistanceLiabilityNoncurrent.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
| Line item | December 31, 2025 | June 30, 2026 |
|---|---|---|
| Long-term liabilities: | ||
| Operating lease liability | 137,403 | 129,948 |
| Deferred revenue | 3,500 | 40,450 |
| Deferred government contributions | 174,453 | 178,254 |
| Other long-term liabilities | 10,383 | 9,714 |
| Total long-term liabilities | 325,739 | 358,366 |
| Total liabilities | 390,046 | 411,555 |
| Commitments and contingencies |
Item 1. Financial Statements (Unaudited)
FAQ
- What is AbCellera Biologics Inc.'s noncurrent unearned government incentives?
- AbCellera Biologics Inc. (ABCL) reported noncurrent unearned government incentives of $178.25M in Q2 2026.
- How has AbCellera Biologics Inc.'s noncurrent unearned government incentives changed year-over-year?
- AbCellera Biologics Inc.'s noncurrent unearned government incentives increased by 6.4% year-over-year, from $167.53M to $178.25M.
- What is the long-term trend for AbCellera Biologics Inc.'s noncurrent unearned government incentives?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s noncurrent unearned government incentives has grown at a 34.9% compound annual growth rate (CAGR), from $95.92M to $174.45M.
- What does noncurrent unearned government incentives mean?
- Noncurrent unearned government incentives as reported by AbCellera Biologics Inc. Common Shares.
Ask your AI about AbCellera Biologics Inc.'s noncurrent unearned government incentives.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude